Polaryx Therapeutics, Inc. (PLYX)
Nasdaq: PLYX · Pharmaceutical Preparations · Paramus, NJ · filing with the SEC since 2025
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 |
|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 |
| Report filed | Mar 24, 2026 | · |
| Research and development | 6,266 | 2,811 |
| General and administrative | 1,555 | 1,541 |
| Total operating expenses | 7,821 | 4,352 |
| Operating income | -7,821 | -4,352 |
| Income before income taxes | -8,985 | -30,356 |
| Net income | -8,985 | -30,356 |
| Earnings per share, basic | -0.20 | -0.89 |
| Earnings per share, diluted | -0.20 | -0.89 |
| Weighted average shares, basic | 45,422,581 | 34,200,660 |
| Weighted average shares, diluted | 45,422,581 | 34,200,660 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding